New research suggests that patients who stop using popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Findings released in a major health publication points out that while overweight individuals often shed a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing such medications need to be cognizant of the danger of rapid weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.
This pace of recovery means a return to pre-treatment weight within about 18 months.
Weighing Treatments
The analysis, which examined dozens of studies involving thousands of participants, contrasted the effects of the injectable medications with older methods.
Scientists point out that people who shed pounds through lifestyle changes alone usually see a less rapid creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Nutrition scientists believe the way of the injections accounts for the accelerated weight return.
These medications mimic a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than normal could lead to the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians say that, considering the high risk of weight regain, the treatment is often life-long.
This view is reinforced by pharmaceutical companies, who say that the results "highlight the chronic character of obesity," akin to managing diseases like high blood pressure.
User Experiences
Users who have come off the jabs explain a powerful resurgence of hunger.
"It was like something activating and you become starving," recalled an individual.
This difficulty is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment.
Growing Adoption
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Adoption is greater among females than males.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, experts emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on integrated lifestyle support.
